Literature DB >> 15640650

Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.

Fabienne Venet1, Alexandre Pachot, Anne-Lise Debard, Julien Bohé, Jacques Bienvenu, Alain Lepape, Guillaume Monneret.   

Abstract

OBJECTIVE: The elevation of the percentage of regulatory CD4+CD25+ T lymphocytes (Treg) has been recently described during septic shock. The objective of the present study was to investigate whether this increased percentage was due to Treg proliferation.
DESIGN: Observational study.
SETTING: Adult intensive care units in a university hospital.
SUBJECTS: Patients with septic shock (n = 54) and healthy individuals (n = 30).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In patients, we first confirmed the increased percentage of Treg among CD4+ lymphocytes in comparison with healthy individuals. Surprisingly, regarding absolute counting, we demonstrated that both T CD4+ lineages (CD25+ and CD25-) were diminished immediately after the onset of shock. Then, whereas Treg returned rapidly to healthy donors values, CD4+CD25- T lymphocytes remained dramatically reduced. Finally, Foxp3 (Treg-related gene) messenger RNA quantification enabled us to definitively rule out a lack of proliferation since it was not increased during shock.
CONCLUSION: The increased percentage of Treg after shock is due not to their proliferation but to a decrease in CD4+CD25- T lymphocyte number. We hypothesize that it might be due to a resistance of Treg to apoptosis processes occurring during septic shock.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15640650     DOI: 10.1097/01.ccm.0000145999.42971.4b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  60 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 2.  Immunoparalysis and adverse outcomes from critical illness.

Authors:  W Joshua Frazier; Mark W Hall
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

3.  The kinetics of T regulatory cells in shock: beyond sepsis.

Authors:  Eirini Christaki; Eleni Patrozou
Journal:  Crit Care       Date:  2010-03-19       Impact factor: 9.097

Review 4.  The role of regulatory T cells in immune dysfunction during sepsis.

Authors:  Chao Cao; Tao Ma; Yan-Fen Chai; Song-Tao Shou
Journal:  World J Emerg Med       Date:  2015

5.  Purification methods: a way to treat severe acute inflammation related to sepsis?

Authors:  Anne Claire Lukaszewicz; Didier Payen
Journal:  Crit Care       Date:  2013-06-21       Impact factor: 9.097

6.  Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism.

Authors:  Jacqueline Unsinger; Hirotaka Kazama; Jacqueline S McDonough; Thomas S Griffith; Richard S Hotchkiss; Thomas A Ferguson
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

7.  Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner.

Authors:  Alexandra C Bolognese; Archna Sharma; Weng-Lang Yang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

8.  The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states.

Authors:  François Hein; Frédéric Massin; Aurélie Cravoisy-Popovic; Damien Barraud; Bruno Levy; Pierre-Edouard Bollaert; Sébastien Gibot
Journal:  Crit Care       Date:  2010-02-15       Impact factor: 9.097

9.  Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway.

Authors:  Rui Bao; Jiong Hou; Yan Li; Jinjun Bian; Xiaoming Deng; Xiaoyan Zhu; Tao Yang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 10.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.